These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37188773)

  • 1. Characteristics and outcomes of neonatal opioid withdrawal syndrome in preterm infants: a retrospective cohort study in the current era.
    Heyward A; Minich N; Hoffman AC; Hibbs AM; Zhao L; Crowley M
    J Perinatol; 2023 Jul; 43(7):909-915. PubMed ID: 37188773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
    Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
    JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Neonatal Opioid Withdrawal Syndrome Severity as a Function of Maternal Buprenorphine Dose and Umbilical Cord Tissue Concentrations.
    Rana D; McLeod AR; Gaston PK; Hill DM; Pourcyrous M
    Ann Pharmacother; 2023 Aug; 57(8):892-898. PubMed ID: 36321504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery timing for the opioid-exposed infant.
    Sanusi A; Gray M; Xue Y; Mohr S; Curtis P; Dismukes J; Gentle S; Szychowski JM; Brocato B; Casey B; Harper L; Sinkey R
    Am J Obstet Gynecol MFM; 2022 Nov; 4(6):100719. PubMed ID: 35977700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the Finnegan scoring system: Novel assessment and diagnostic techniques for the opioid-exposed infant.
    Schiff DM; Grossman MR
    Semin Fetal Neonatal Med; 2019 Apr; 24(2):115-120. PubMed ID: 30738754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach.
    Velez ML; Jordan CJ; Jansson LM
    Neurotoxicol Teratol; 2021; 88():107020. PubMed ID: 34419619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Eat, Sleep, and Console on Infants Pharmacologically Treated for Opioid Withdrawal: A Post Hoc Subgroup Analysis of the ESC-NOW Randomized Clinical Trial.
    Devlin LA; Hu Z; Merhar SL; Ounpraseuth ST; Simon AE; Lee JY; Das A; Crawford MM; Greenberg RG; Smith PB; Higgins RD; Walsh MC; Rice W; Paul DA; Maxwell JR; Fung CM; Wright T; Ross J; McAllister JM; Crowley M; Shaikh SK; Christ L; Brown J; Riccio J; Wong Ramsey K; Braswell EF; Tucker L; McAlmon K; Dummula K; Weiner J; White JR; Newman S; Snowden JN; Young LW;
    JAMA Pediatr; 2024 Jun; 178(6):525-532. PubMed ID: 38619854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
    Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent Impact of Eat, Sleep, Console Assessment on Neonatal Opioid Withdrawal Syndrome.
    Chyi LJ; Li S; Lee C; Walsh EM; Kuzniewicz MW
    Clin Pediatr (Phila); 2024 Sep; 63(8):1097-1105. PubMed ID: 37798943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.
    Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW
    Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero.
    Lawlor ML; Shook LA; McQuerry K; Srinivasan A; Johnson QB; Chavan NR; Critchfield AS
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376
    [No Abstract]   [Full Text] [Related]  

  • 12. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?
    Gersch H; Shah D; Chroust A; Bailey B
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial differences in opioid withdrawal syndrome among neonates with intrauterine opioid exposure.
    Pourcyrous M; Elabiad MT; Rana D; Gaston KP; DeBaer L; Dhanireddy R
    Pediatr Res; 2021 Aug; 90(2):459-463. PubMed ID: 33214673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental DNA methylation profiles in opioid-exposed pregnancies and associations with the neonatal opioid withdrawal syndrome.
    Radhakrishna U; Vishweswaraiah S; Uppala LV; Szymanska M; Macknis J; Kumar S; Saleem-Rasheed F; Aydas B; Forray A; Muvvala SB; Mishra NK; Guda C; Carey DJ; Metpally RP; Crist RC; Berrettini WH; Bahado-Singh RO
    Genomics; 2021 May; 113(3):1127-1135. PubMed ID: 33711455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome.
    Bhatt-Mehta V; Jing X; Wang X; Zhu HJ
    Pharmacotherapy; 2024 Jan; 44(1):22-27. PubMed ID: 37574548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome.
    Merhar SL; Ounpraseuth S; Devlin LA; Poindexter BB; Young LW; Berkey SD; Crowley M; Czynski AJ; Kiefer AS; Whalen BL; Das A; Fuller JF; Higgins RD; Thombre V; Lester BM; Smith PB; Newman S; Sánchez PJ; Smith MC; Simon AE;
    Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33632932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure.
    Morris E; Bardsley T; Schulte K; Seidel J; Shakib JH; Buchi KF; Fung CM
    Am J Perinatol; 2022 Mar; 39(4):387-393. PubMed ID: 32892326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS.
    Velez ML; Jordan C; Jansson LM
    Neurotoxicol Teratol; 2021; 88():107032. PubMed ID: 34600100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome.
    Singleton R; Rutz S; Day G; Hammes M; Wilson AS; Herrick M; Mazut C; Brunner L; Prince J; Desnoyers C; Shaw J; Hirschfeld M; Palis H; Slaunwhite A
    J Addict Med; 2022 Nov-Dec 01; 16(6):e366-e373. PubMed ID: 35245916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Influence of Mediators on the Relationship Between Antenatal Opioid Agonist Exposure and the Severity of Neonatal Opioid Withdrawal Syndrome.
    Devlin LA; Hu Z; Ounpraseuth S; Simon AE; Annett RD; Das A; Fuller JF; Higgins RD; Merhar SL; Smith PB; Crawford MM; Cottrell LE; Czynski AJ; Newman S; Paul DA; Sánchez PJ; Semmens EO; Smith MC; Whalen BL; Snowden JN; Young LW;
    Matern Child Health J; 2023 Jun; 27(6):1030-1042. PubMed ID: 36905529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.